Prospective Multicentre Study on the Epidemiology and Current Therapeutic Management of Severe Bronchiolitis in Spain

Table 4

Nebulised treatment of patients included in the BRUCIP study. PSS: physiological saline solution; HSS: hypertonic saline solution.

Factors analysed		Duration (days)	Length of PICU stay
No nebulisation	62 (23.7%)		7.16 ± 5.99	0.141
Salbutamol inhaled	6 (2.3%)	3.58 ± 3.11	11.6 ± 8.35
Salbutamol nebulised	17 (6.5%)	4.25 ± 6.66	9.18 ± 8.52
Adrenaline + PSS nebulised	38 (14.5%)	2.06 ± 2.43	8.0 ± 4.35
Adrenaline + 3% HSS nebulised	24 (9.2%)	4.43 ± 4.27	8.16 ± 3.74
3% HSS	11 (4.2%)	4.16 ± 3.54	10.0 ± 6.92
Several nebulisations	104 (39.7%)		7.78 ± 4.18